Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_assertion description "[Imatinib is effective in patients with increased mast cells and eosinophils associated with FIP1L1/PDGFRA+ (e.g., myeloid neoplasm with eosinophilia and rearrangement of PDGFRA) or rare patients with SM associated with KIT mutations outside of exon 17.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_assertion evidence source_evidence_literature NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_assertion SIO_000772 21641642 NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_assertion wasDerivedFrom befree-20150227 NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_assertion wasGeneratedBy ECO_0000203 NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP526005.RAfP5xiRfSRwSM1dMfAvm3fq8QE5tcgSFvPgf6-k94nPo130_provenance.